Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GNLX compared with CRIS: revenue, margins and what each company keeps, and the suppliers and customers both name
GNLX
Genelux Corp
Change
Mkt cap
Revenue
Revenue
CRIS
Curis Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
GNLX
Genelux Corp
vs
CRIS
Curis Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only GNLX
2
—
Newsoara
unlisted
customer
—
Newsoara BioPharma
unlisted
customer
Shared
0
No shared counterparties.
Only CRIS
1
—
Genentech
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
GNLX
Genelux Corp
Change
2.00
▼
−3.84%
· post 2.00
Mkt cap
$94.1M
Revenue
$8,000
Q4 FY25
Revenue
—
CRIS
Curis Inc
Change
0.65
▲
+8.33%
· post 0.69
Closed
Nov 2 '26
Mkt cap
$1.3M
Revenue
$1M
Q4 FY25
Revenue
$9M
FY25
vs
Compare
Closed
Nov 2 '26
GNLX
Genelux Corp
vs
CRIS
Curis Inc
2.00
▼
−3.84%
post 2.00
Price
0.65
▲
+8.33%
post 0.69
$94.1M
Mkt cap
$1.3M
Q4 FY25
$8,000
Revenue
$1M
Q4 FY25
—
Revenue
$9M
FY25
Change
Change
GNLX
2.00
▼
−3.84%
vs
CRIS
0.65
▲
+8.33%
Closed
Nov 2 '26